Douglas Kyle Hogarth to Lung Neoplasms
This is a "connection" page, showing publications Douglas Kyle Hogarth has written about Lung Neoplasms.
Connection Strength
2.135
-
"Tool-in-lesion" Accuracy of Galaxy System-A Robotic Electromagnetic Navigation BroncHoscopy With Integrated Tool-in-lesion-Tomosynthesis Technology: The MATCH Study. J Bronchology Interv Pulmonol. 2024 Jan 01; 31(1):23-29.
Score: 0.396
-
Augmented Fluoroscopy: A New and Novel Navigation Platform for Peripheral Bronchoscopy. J Bronchology Interv Pulmonol. 2021 Apr 01; 28(2):116-123.
Score: 0.327
-
Lung Nodule Management: An Interventional Pulmonology Perspective. Semin Respir Crit Care Med. 2018 Dec; 39(6):661-666.
Score: 0.281
-
Use of augmented fluoroscopic imaging during diagnostic bronchoscopy. Future Oncol. 2018 Sep; 14(22):2247-2252.
Score: 0.267
-
Central Airway Obstruction: Benign Strictures, Tracheobronchomalacia, and Malignancy-related Obstruction. Chest. 2016 08; 150(2):426-41.
Score: 0.229
-
Microwave ablation via a flexible catheter for the treatment of nonsurgical peripheral lung cancer: A pilot study. Thorac Cancer. 2022 04; 13(7):1014-1020.
Score: 0.087
-
NAVIGATE 24-Month Results: Electromagnetic Navigation Bronchoscopy for Pulmonary Lesions at 37 Centers in Europe and the United States. J Thorac Oncol. 2022 04; 17(4):519-531.
Score: 0.086
-
Predicting Lymph Node Metastasis in Non-small Cell Lung Cancer: Prospective External and Temporal Validation of the HAL and HOMER Models. Chest. 2021 09; 160(3):1108-1120.
Score: 0.082
-
Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis. Curr Med Res Opin. 2020 09; 36(9):1497-1505.
Score: 0.078
-
Bronchoscopic Ablative Therapies for Malignant Central Airway Obstruction and Peripheral Lung Tumors. Ann Am Thorac Soc. 2019 10; 16(10):1220-1229.
Score: 0.074
-
Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer. Int J Cancer. 2018 06 01; 142(11):2355-2362.
Score: 0.066
-
Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 03; 19(2):e227-e233.
Score: 0.064
-
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation. Oncotarget. 2016 Apr 05; 7(14):18876-86.
Score: 0.058
-
Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer. Lung Cancer. 2006 Nov; 54(2):243-5.
Score: 0.030
-
Safety of pacemakers and defibrillators in electromagnetic navigation bronchoscopy. Chest. 2013 Jan; 143(1):75-81.
Score: 0.012